Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
Phase 1 Unknown
30 enrolled
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Phase 1 Unknown
68 enrolled
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Phase 1 Unknown
71 enrolled
MK-3475-E90
Phase 1 Unknown
54 enrolled
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
Phase 1 Unknown
90 enrolled
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
Phase 1 Unknown
17 enrolled
USmBRT-H
Phase 1 Unknown
20 enrolled
EpCAM CAR-T for Treatment of Advanced Solid Tumors
Phase 1 Unknown
30 enrolled
Olaparib and Radiotherapy in Head and Neck Cancer
Phase 1 Unknown
12 enrolled
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
Phase 1 Unknown
73 enrolled
IMMUNOs-SBRT
Phase 1 Unknown
92 enrolled
Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Phase 1 Unknown
65 enrolled
Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study
Phase 1 Unknown
36 enrolled
ST-BNCT2001
Phase 1 Unknown
30 enrolled
GEN602
Phase 1 Unknown
127 enrolled
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
Phase 1 Unknown
90 enrolled
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Phase 1 Unknown
100 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
MICROBIOME
Phase 1 Unknown
120 enrolled
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Phase 1 Unknown
58 enrolled
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Phase 1 Unknown
12 enrolled
Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Phase 1 Unknown
41 enrolled
RISE-HN
Phase 1 Unknown
13 enrolled
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
Phase 1 Unknown
20 enrolled
BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
Phase 1 Unknown
18 enrolled
MRL-02
Phase 1 Unknown
24 enrolled
SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1 Unknown
91 enrolled
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
Phase 1 Unknown
98 enrolled
NeoNivo
Phase 1 Unknown
17 enrolled
Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC
Phase 1 Unknown
20 enrolled
Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer
Phase 1 Unknown
20 enrolled
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
Phase 1 Unknown
33 enrolled
MESRIX-SAFETY
Phase 1 Unknown
10 enrolled
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)
Phase 1 Unknown
20 enrolled
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
Phase 1 Unknown
10 enrolled
Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients
Phase 1 Unknown
27 enrolled
COTI2-101
Phase 1 Unknown
51 enrolled
Investigator Initiated Phase 1 Study of TBI-1301
Phase 1 Unknown
9 enrolled
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
Phase 1 Unknown
49 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Phase 1 Unknown
69 enrolled
Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1 Unknown
55 enrolled
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Phase 1 Unknown
200 enrolled
Calcium Electroporation for Head and Neck Cancer
Phase 1 Unknown
6 enrolled
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1 Unknown
18 enrolled
A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors
Phase 1 Unknown
20 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
Phase 1 Unknown
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
Phase 1 Unknown
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
Phase 1 Unknown
14 enrolled
Study of Chemo-Immunotherapy in Head and Neck Cancer Patients
Phase 1 Unknown
10 enrolled